Fifth disease spreads mainly through respiratory droplets, the tiny particles released when an infected person coughs, sneezes, or talks. The tricky part: people are most contagious before they know they’re sick, during the early phase when viral levels in saliva and respiratory secretions are at their peak. By the time the telltale “slapped cheek” rash appears a few weeks after infection, the person is generally no longer spreading the virus.
The Main Route: Respiratory Droplets
Fifth disease is caused by parvovirus B19, a seasonal respiratory virus. It travels the same way a cold does. When someone carrying the virus breathes, coughs, or sneezes near you, droplets containing the virus can land on your mouth, nose, or eyes. Sharing cups, utensils, or close face-to-face contact in schools and daycare settings makes transmission even easier.
The virus can also spread through saliva, which is why young children who share toys or put objects in their mouths are especially prone to picking it up. Outbreaks tend to cluster in late winter and spring, following the pattern of many respiratory viruses.
Why the Contagious Window Is So Misleading
The frustrating reality of fifth disease is that the contagious period is essentially invisible. After exposure, the virus quietly replicates for roughly one to two weeks. During this early phase, the infected person may feel completely fine or develop only mild, nonspecific symptoms like a low fever, headache, or body aches. These look like any ordinary cold and rarely raise alarm.
This is precisely when viral loads are highest and the person is shedding the most virus. Once the immune system starts producing antibodies (typically 10 to 12 days after infection), the rash and joint pain that follow are actually signs the body is fighting back. At that point, the person is much less likely to be contagious. That gap between peak infectiousness and recognizable symptoms is why fifth disease moves so easily through schools and households before anyone realizes it’s circulating.
Spread During Pregnancy
Parvovirus B19 can pass from a pregnant person to the fetus through the bloodstream. This is called vertical transmission. In most documented cases, the fetus is not harmed. Studies from the U.K. found that fewer than one-third of maternal infections resulted in the virus reaching the fetus at all.
When the virus does cross the placenta, serious complications are still uncommon but possible. The primary risk is a condition called hydrops fetalis, where fluid accumulates abnormally in fetal tissues. Preliminary data from the CDC suggests the risk of fetal death following a confirmed maternal infection is less than 10%, and one prospective study tracking 49 infected pregnancies to term recorded fetal loss in about 4% of cases. These numbers underscore that while most pregnancies proceed normally after infection, the risk is real enough that pregnant people exposed to fifth disease should talk with their healthcare provider about testing.
Spread Through Blood Products
Fifth disease can also spread through blood transfusions and plasma-derived products, though this is far less common than respiratory transmission. The virus is remarkably resistant to the standard methods used to inactivate viruses in blood products, including heat treatment and chemical processing. Pooled plasma products like clotting factor concentrates have been linked to multiple transmissions, which is particularly relevant for people with hemophilia who receive these products regularly.
Transmission through a single blood donation is rare. Only five cases of parvovirus B19 infection transmitted by individual blood components (mostly red blood cell transfusions) have been documented in the medical literature. However, one study estimated an overall transmission rate of about 0.12% per transfusion, which, given the volume of transfusions performed in the U.S. each year, could still translate to a significant number of infections.
Who Stays Contagious Longer
In a healthy person, the immune system clears the virus within a couple of weeks, and once the rash appears, they’re essentially done being contagious. People with weakened immune systems face a different situation. Because their bodies can’t mount a strong enough antibody response to shut down the virus, they may continue shedding parvovirus B19 for weeks or even months. This prolonged infectiousness makes them a potential ongoing source of transmission in healthcare settings or shared living environments.
People with certain blood disorders, such as sickle cell disease, are also at higher risk for complications, not because they spread the virus differently, but because parvovirus B19 temporarily shuts down red blood cell production. In someone whose red blood cells already break down faster than normal, this can trigger a sudden, severe drop in blood counts.
Prevention Without a Vaccine
There is no vaccine for parvovirus B19, so prevention comes down to basic hygiene. Frequent handwashing with soap and water is the single most effective step, especially in childcare settings and healthcare facilities. Avoiding close contact with anyone who has cold-like symptoms during an active outbreak can help, but since infected people look and feel fine during their most contagious days, this is easier said than done.
The CDC considers it safe for children and adults to return to school or work once the rash appears, since that stage of the illness is no longer significantly contagious. Excluding a child with the rash does little to prevent spread because the window for transmission has already passed. For the same reason, closing a classroom or canceling activities after a case is identified is generally not recommended. The exposure already happened days or weeks before anyone noticed.